recent publications

• academic article

  • Fallahi, M., Amelio, A. L., Cleveland, J. L., Rounbehler, R. J. CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin PLoS One  2014 9:e115517  DOI:10.1371/journal.pone.0115517  PMID:25541715  PMCID:PMC4277357
  • Doherty, J. R., Yang, C., Scott, K. E. N., Cameron, M. D., Fallahi, M., Li, W., Hall, M. A., Amelio, A. L., Mishra, J. K., Li, F., Tortosa, M., Genau, H. M., et al. Blocking lactate export by inhibiting the Myc target MCT1 disables glycolysis and glutathione synthesis Cancer Research  2014 74:908-920  DOI:10.1158/0008-5472.can-13-2034  PMID:24285728  PMCID:PMC3946415
  • Rounbehler, R. J., Fallahi, M., Yang, C. Y., Steeves, M. A., Li, W. M., Doherty, J. R., Schaub, F. X., Sanduja, S., Dixon, D. A., Blackshear, P. J., Cleveland, J. L. Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state Cell  2012 150:563-574  DOI:10.1016/j.cell.2012.06.033  PMID:22863009  PMCID:PMC3422762
  • Rounbehler, R. J., Li, W. M., Hall, M. A., Yang, C. Y., Fallahi, M., Cleveland, J. L. Targeting ornithine decarboxylase impairs development of mycn-amplified neuroblastoma Cancer Research  2009 69:547-553  DOI:10.1158/0008-5472.can-08-2968  PMID:19147568  PMCID:PMC2749594